JBIO
Jade Biosciences, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−1.05%
vs ±18.9% implied · ×0.06
shaded = implied · ▲▼ = realized
No thesis.
Jade Biosciences, Inc.
14.07
+0.01 · +0.07%
post 13.90 −1.21%
Largest filed tie
—
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $202.8M | 12.50% | +28.81% | |
| 2 | Jupiter TopcoJupiter Topco | $139.4M | 8.59% | — | |
| 3 | Fairmount Funds ManagementFairmount Funds | $101.2M | 6.24% | 0.00% | |
| 4 | RA Capital ManagementRA Capital Management | $81.6M | 5.03% | 0.00% | |
| 5 | VR AdviserVR Adviser | $71.6M | 4.41% | 0.00% | |
| 6 | Bellevue GroupBellevue | $67.9M | 4.19% | −12.67% | |
| 7 | Paradigm Biocapital AdvisorsParadigm Biocapital | $63.5M | 3.91% | new | |
| 8 | BlackRockBlackRockindex-like | $62.2M | 3.84% | +21.07% | |
| 9 | Franklin ResourcesFranklin Resources | $62.0M | 3.82% | new | |
| 10 | State StreetState Streetindex-like | $51.9M | 3.20% | +256.16% | |
| 11 | Vanguard Capital ManagementVanguardindex-like | $49.9M | 3.08% | +24.94% | |
| 12 | Adage Capital Partners GPAdage Capital Partners GP | $42.5M | 2.62% | new | |
| 13 | Polar Capital HoldingsPolar Capital | $41.0M | 2.53% | new | |
| 14 | Avidity Partners ManagementAvidity Partners | $37.8M | 2.33% | +21.42% | |
| 15 | Remedium Capital PartnersRemedium Capital Partners | $35.1M | 2.16% | 0.00% | |
| 16 | Soleus Capital ManagementSoleus | $34.5M | 2.12% | +94.63% | |
| 17 | JPMorgan ChaseJPMorgan Chase | $32.6M | 2.01% | new | |
| 18 | Baker Bros. AdvisorsBaker Bros. | $27.3M | 1.69% | −25.03% | |
| 19 | Logos Global ManagementLogos Global | $25.0M | 1.54% | +181.25% | |
| 20 | Versant Venture ManagementVersant Venture | $22.0M | 1.36% | −35.00% | |
| 21 | Acorn Capital AdvisorsAcorn Capital | $21.9M | 1.35% | +25.42% | |
| 22 | Geode Capital ManagementGeodeindex-like | $21.9M | 1.35% | +19.78% | |
| 23 | Citadel AdvisorsCitadel | $20.7M | 1.27% | +577.30% | |
| 24 | Foresite Capital Management VIForesite Capital Management VI | $19.7M | 1.21% | +177.08% | |
| 25 | Balyasny Asset ManagementBalyasny | $19.5M | 1.20% | +118.32% |
152 managers report $1.6B of Jade Biosciences on form 13F for the quarter ended Jun 30 '26. 23 of them hold 80% of it; FMR is largest at 12.50%.
Expected move
Inputs8Q avg ±7.6%·×3.87·rich
straddle ±31.0%
spot 13.93exp Nov 20ATM strike 15ATM straddle 5.08IV 197%